Efficacy of Mitomycin C in Endoscopic Dacryocystorhinostomy: A Systematic Review and Meta-Analysis

NCT01772277 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 400

Last updated 2014-02-13

No results posted yet for this study

Summary

To assess the efficacy and safety of local application of intraoperative mitomycin C (MMC) at osteotomy site in endoscopic dacryocystorhinostomy(EN-DCR).

Conditions

  • Dacryocystitis

Sponsors & Collaborators

  • Wenzhou Medical University

    collaborator OTHER
  • Yifan Feng

    lead OTHER

Principal Investigators

  • Shiming Cheng, MD · Eye Hospital, Wenzhou Medical College, China

Eligibility

Min Age
18 Years
Max Age
80 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2012-12-31
Primary Completion
2014-02-28
Completion
2014-02-28

Countries

  • China

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01772277 on ClinicalTrials.gov